We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Placing a veterinary medicine on the market, including non-medicinal products, medicinal words and phrases, how to obtain advice, report non-compliance.
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Information on road traffic devices, such as breath-testing, speed cameras and immobilisation devices.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
How to use PharmaQC to access pharmaceutical suppliers, Quality Control (QC) pharmacists and Commercial Medicines Unit (CMU) buyers.
Registers of authorised manufacturers, wholesale dealer sites and retailers.
AMRHAI (antimicrobial resistance and healthcare associated infections) is the national reference unit for investigating AMR in healthcare-associated bacteria.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Information and resources to support commissioners, service providers and others to reduce harm and prevent deaths related to substance misuse.
Advice for medical professionals to follow when assessing drivers with drug or alcohol misuse or dependence.
The process for the simultaneous review of veterinary drug submissions by Health Canada’s Veterinary Drugs Directorate and the UK's Veterinary Medicines Directorate.
List of Field Safety Notices from 1 to 5 July 2024.
Terms of reference of a review into enhancing our legislative response to new psychoactive substances.
The process for the simultaneous review of veterinary medicine submissions by New Zealand’s Ministry for Primary Industries (MPI) and the UK's Veterinary Medicines Directorate.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
AVU provides services for genotypic antiviral resistance testing of HIV and HCV, investigation of HIV transmission events and HSV antiviral resistance testing by phenotyping.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).